Adam Carpenter is a Neurology physician affiliated with University of Minnesota. OpenAlex indexes 23 publications with 1,099 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
420 Delaware St SE, Clinic 1a
Phillips Wangensteen Building
Minneapolis, MN 55455
Telephone
612-626-5890Registry record last updated 27 May 2010.
Clinical trials
- Exercise in Multiple Sclerosis
Sponsor: University of Minnesota
- ACTH in Progressive Forms of MS
Sponsor: University of Minnesota
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20242 payments
- Sumitomo Pharma America, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
60.5%Potassium Channel Blocker13.8%Dalfampridine Er88%Ampyra12%Part D<11 patientsGabapentinoids13.8%Gabapentin77%Pregabalin23%Part D<11 patients+ 11 more classes in this area
Musculoskeletal
20.1%gamma-Aminobutyric Acid-ergic Agonist15.5%Baclofen100%Part D≥30 patientsCentral alpha-2 Adrenergic Agonist4.6%Tizanidine Hcl100%Part D<11 patientsCancer & immunology
8.5%Other immunostimulants2.5%Glatiramer Acetate100%Part D<11 patientsPyrimidine Synthesis Inhibitor2.3%Aubagio52%Teriflunomide48%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of Lupus Anticoagulant with Brain Atrophy in Gulf War Illness (GWI)
Journal of Immunological Sciences
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Vicki Morrison, MD
University of Minnesota
Maria Hordinsky, MD
University of Minnesota
Paul Tuite, MD
University of Minnesota
Allyson Hart, MD
University of Minnesota
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”